Incretin Atlas·MoleculesTrialsOutcomesTimelinePipelineAboutMedical Adviser's Group
Incretin Atlas › Molecules › CT-996

CT-996

GLP-1 (small molecule) · oral · Roche

Data cut 12 November 2026 · page built 16 November 2026 · 0 trial arms · 0 trials with results · 0 registered trials · see on the pipeline board

Summary

Also known as
Roche / Carmot
Mechanism
GLP-1 (small molecule)
Route
oral
Company
Roche
Highest development stage
phase 2
Status (as of data cut)
Phase 2 verify
Next milestone
Phase 2 readout

Trial arms: weight, HbA1c and tolerability

No trial arms with extracted efficacy or tolerability data yet.

Primary sources

No source recorded.

How to cite this page

Medical Adviser's Group. Incretin Atlas: CT-996. Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/ct-996/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.

Cite the primary publication for any single result; every value above links to it.